Irish company APC partners with Australian biotechnology firm Vaxine to accelerate the development and delivery of new Covid-19 vaccine candidate
APC and Vaxine partner to accelerate development of COVAX-19, combining BioACHIEVE process development with Advax adjuvant technology to reduce vaccine timelines.